Surui Yao

2.2k total citations · 1 hit paper
41 papers, 1.6k citations indexed

About

Surui Yao is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Surui Yao has authored 41 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 30 papers in Cancer Research and 6 papers in Immunology. Recurrent topics in Surui Yao's work include Cancer-related molecular mechanisms research (14 papers), RNA modifications and cancer (13 papers) and Extracellular vesicles in disease (10 papers). Surui Yao is often cited by papers focused on Cancer-related molecular mechanisms research (14 papers), RNA modifications and cancer (13 papers) and Extracellular vesicles in disease (10 papers). Surui Yao collaborates with scholars based in China, Japan and United States. Surui Yao's co-authors include Zhaohui Huang, Yuan Yin, Zehua Bian, Bojian Fei, Yuyang Feng, Xin Jin, Jiwei Zhang, Leyuan Zhou, Shenglin Huang and Kaisa Cui and has published in prestigious journals such as Journal of Biological Chemistry, Oncogene and Clinical Cancer Research.

In The Last Decade

Surui Yao

39 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Colorectal Cancer‐Derived Small Extracellular Vesicles Promote Tumor Immune Evasion by Upregulating PD‐L1 Expression in Tumor‐Associated Macrophages

2022 165 citations Yuan Yin, Bingxin Liu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Surui Yao China	19	1.2k	964	290	269	126	41	1.6k
Leyuan Zhou China	15	843 0.7×	762 0.8×	259 0.9×	288 1.1×	124 1.0×	37	1.3k
Bojian Fei China	21	1.5k 1.3×	1.4k 1.4×	295 1.0×	370 1.4×	163 1.3×	55	2.1k
Kaisa Cui China	21	864 0.7×	532 0.6×	279 1.0×	257 1.0×	141 1.1×	37	1.2k
Fuqing Hu China	16	873 0.7×	449 0.5×	304 1.0×	242 0.9×	130 1.0×	20	1.3k
Junlu Wu China	15	809 0.7×	640 0.7×	250 0.9×	220 0.8×	103 0.8×	43	1.2k
Yushuai Mi China	13	871 0.7×	618 0.6×	253 0.9×	226 0.8×	109 0.9×	19	1.2k
Sadegh Babashah Iran	23	1.4k 1.2×	1.1k 1.1×	135 0.5×	208 0.8×	86 0.7×	70	1.8k
Chengwu Zeng China	22	1.6k 1.4×	1.2k 1.2×	280 1.0×	323 1.2×	133 1.1×	60	2.1k
Dongya Zhang China	10	939 0.8×	782 0.8×	156 0.5×	231 0.9×	78 0.6×	10	1.2k
Dandan Wang China	21	1000 0.9×	812 0.8×	140 0.5×	173 0.6×	115 0.9×	52	1.3k

Countries citing papers authored by Surui Yao

Since Specialization

Citations

This map shows the geographic impact of Surui Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Surui Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Surui Yao more than expected).

Fields of papers citing papers by Surui Yao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Surui Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Surui Yao. The network helps show where Surui Yao may publish in the future.

Co-authorship network of co-authors of Surui Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Surui Yao. A scholar is included among the top collaborators of Surui Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Surui Yao. Surui Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Jiuming, Ying Chen, Zhiang Liu, et al.. (2025). Monounsaturated fatty acids promote cancer radioresistance by inhibiting ferroptosis through ACSL3. Cell Death and Disease. 16(1). 184–184. 6 indexed citations

Wang, Fengyuan, Surui Yao, Zihan Zheng, et al.. (2024). Adipose-Derived exosome from Diet-Induced-Obese mouse attenuates LPS-Induced acute lung injury by inhibiting inflammation and Apoptosis: In vivo and in silico insight. International Immunopharmacology. 139. 112679–112679. 2 indexed citations

Yang, Chunyu, Ge Gao, Yuan Yin, et al.. (2024). RTEL1 is upregulated in gastric cancer and promotes tumor growth. Journal of Cancer Research and Clinical Oncology. 151(1). 23–23. 2 indexed citations

Chen, Yanyan, Meimei Zhang, Surui Yao, et al.. (2024). Metformin suppresses gastric cancer progression by disrupting the STAT1-PRMT1 axis. Biochemical Pharmacology. 226. 116367–116367.

Chen, Ying, Liang Gong, Yulin Cao, et al.. (2024). Reprogramming tumor-associated macrophages by a dually targeted milk exosome system as a potent monotherapy for cancer. Journal of Controlled Release. 366. 395–409. 36 indexed citations

Yang, Fan, et al.. (2023). Up-regulation of STRA6 predicts poor prognosis and contributes to oxaliplatin resistance in colorectal cancer. Pathology - Research and Practice. 243. 154352–154352. 3 indexed citations

Yao, Surui, et al.. (2023). Obesity Paradox in Lung Diseases: What Explains It?. Obesity Facts. 16(5). 411–426. 18 indexed citations

Yao, Surui, et al.. (2023). Gamma-Aminobutyric Acid Type A Receptor Subunit Pi is a potential chemoresistance regulator in colorectal cancer. Molecular Biology Reports. 50(4). 3167–3177. 3 indexed citations

Gong, Zhicheng, Yanyan Chen, Meimei Zhang, et al.. (2023). KDM4C-mediated senescence defense is a targetable vulnerability in gastric cancer harboring TP53 mutations. Clinical Epigenetics. 15(1). 163–163. 13 indexed citations

10.

Gong, Liang, Lu Tian, Kaisa Cui, et al.. (2023). An off-the-shelf small extracellular vesicle nanomedicine for tumor targeting therapy. Journal of Controlled Release. 364. 672–686. 24 indexed citations

11.

Teng, Peng, Kaisa Cui, Surui Yao, et al.. (2023). SIRT5-mediated ME2 desuccinylation promotes cancer growth by enhancing mitochondrial respiration. Cell Death and Differentiation. 31(1). 65–77. 35 indexed citations

12.

Wang, Xue, Han Cheng, Jing Zhao, et al.. (2022). Long noncoding RNA DLGAP1-AS2 promotes tumorigenesis and metastasis by regulating the Trim21/ELOA/LHPP axis in colorectal cancer. Molecular Cancer. 21(1). 210–210. 36 indexed citations

13.

Zhang, Han, et al.. (2021). Comprehensive molecular and clinical characterization of SLC1A5 in human cancers. Pathology - Research and Practice. 224. 153525–153525. 10 indexed citations

14.

Zhou, Mingyue, Zehua Bian, Bingxin Liu, et al.. (2021). Long noncoding RNA MCM3AP‐AS1 enhances cell proliferation and metastasis in colorectal cancer by regulating miR‐193a‐5p/SENP1. Cancer Medicine. 10(7). 2470–2481. 25 indexed citations

15.

Cui, Kaisa, Surui Yao, Han Zhang, et al.. (2021). Identification of an immune overdrive high-risk subpopulation with aberrant expression of FOXP3 and CTLA4 in colorectal cancer. Oncogene. 40(11). 2130–2145. 22 indexed citations

16.

Jin, Xin, Yuhang Liu, Jia Zhang, et al.. (2019). A panel of serum exosomal microRNAs as predictive markers for chemoresistance in advanced colorectal cancer. Cancer Chemotherapy and Pharmacology. 84(2). 315–325. 105 indexed citations

17.

Zhang, Jia, Zehua Bian, Xin Jin, et al.. (2019). Long non-coding RNA IQCJ-SCHIP1 antisense RNA 1 is downregulated in colorectal cancer and inhibits cell proliferation. Annals of Translational Medicine. 7(9). 198–198. 12 indexed citations

18.

Bian, Zehua, Jiwei Zhang, Min Li, et al.. (2018). LncRNA–FEZF1-AS1 Promotes Tumor Proliferation and Metastasis in Colorectal Cancer by Regulating PKM2 Signaling. Clinical Cancer Research. 24(19). 4808–4819. 246 indexed citations

19.

Yin, Yuan, Surui Yao, Yaling Hu, et al.. (2017). The Immune-microenvironment Confers Chemoresistance of Colorectal Cancer through Macrophage-Derived IL6. Clinical Cancer Research. 23(23). 7375–7387. 208 indexed citations

20.

Bian, Zehua, Jiwei Zhang, Min Li, et al.. (2017). Long non-coding RNA LINC00152 promotes cell proliferation, metastasis, and confers 5-FU resistance in colorectal cancer by inhibiting miR-139-5p. Oncogenesis. 6(11). 395–395. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact